DK0898969T3 - Neospora-vaccine - Google Patents

Neospora-vaccine

Info

Publication number
DK0898969T3
DK0898969T3 DK98306431T DK98306431T DK0898969T3 DK 0898969 T3 DK0898969 T3 DK 0898969T3 DK 98306431 T DK98306431 T DK 98306431T DK 98306431 T DK98306431 T DK 98306431T DK 0898969 T3 DK0898969 T3 DK 0898969T3
Authority
DK
Denmark
Prior art keywords
neospora vaccine
neospora
vaccine
Prior art date
Application number
DK98306431T
Other languages
Danish (da)
English (en)
Inventor
David Alan Brake
Manuel Campos
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22007613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0898969(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK0898969T3 publication Critical patent/DK0898969T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98306431T 1997-08-26 1998-08-12 Neospora-vaccine DK0898969T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5695697P 1997-08-26 1997-08-26
EP98306431A EP0898969B1 (de) 1997-08-26 1998-08-12 Neospora Impstoff

Publications (1)

Publication Number Publication Date
DK0898969T3 true DK0898969T3 (da) 2005-01-17

Family

ID=22007613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98306431T DK0898969T3 (da) 1997-08-26 1998-08-12 Neospora-vaccine

Country Status (16)

Country Link
US (2) US6787146B2 (de)
EP (2) EP0898969B1 (de)
JP (1) JP3049016B2 (de)
CN (1) CN1211449A (de)
AR (1) AR016396A1 (de)
AT (1) ATE277631T1 (de)
AU (1) AU764455B2 (de)
BR (1) BR9803232A (de)
CA (1) CA2245425C (de)
DE (1) DE69826593T2 (de)
DK (1) DK0898969T3 (de)
ES (1) ES2227783T3 (de)
NZ (1) NZ331529A (de)
PT (1) PT898969E (de)
TW (2) TWI228419B (de)
ZA (1) ZA987662B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020303A1 (en) 1997-10-20 1999-04-29 Bayer Corporation Neospora vaccines
EP0953641A3 (de) * 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
PL216541B1 (pl) * 2002-08-26 2014-04-30 Pfizer Prod Inc Kompozycja immunogenna oraz kompozycja do szczepienia i jej zastosowanie
WO2004037321A2 (en) * 2002-10-25 2004-05-06 University Of Connecticut Health Center Immunotherapy of cancer through controlled cell lysis
US20050164168A1 (en) * 2003-03-28 2005-07-28 Cullum Malford E. Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
CN101831495B (zh) * 2010-04-30 2013-06-19 新疆出入境检验检疫局检验检疫技术中心 一种牛新孢子虫病的检测方法及应用
EP2708237A1 (de) * 2012-09-17 2014-03-19 Université de Droit et de la Santé de Lille 2 Pharmazeutische Zusammensetzung zu deren Verwendung bei der präventiven Behandlung von Infektionen, die durch einen intrazellularen Krankheitserreger, speziell durch Toxoplasma gondii, verursacht werden
WO2014182872A1 (en) 2013-05-08 2014-11-13 Protatek International, Inc. Vaccine for pcv2 and mycoplasma
AU2016347636B2 (en) 2015-10-28 2021-02-18 Universidad Complutense De Madrid Neospora vaccine composition
BR112019006900A2 (pt) 2016-10-05 2019-07-02 Zoetis Services Llc métodos de liofilização que proporcionam protozoários desidratados estáveis para o uso como potentes vacinas vivas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5707617A (en) * 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US6743430B1 (en) 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
WO1997017082A1 (en) 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora

Also Published As

Publication number Publication date
CA2245425A1 (en) 1999-02-26
TWI228419B (en) 2005-03-01
JPH11130683A (ja) 1999-05-18
TW200305433A (en) 2003-11-01
EP1477184A3 (de) 2006-04-12
AU8188498A (en) 1999-03-11
AU764455B2 (en) 2003-08-21
PT898969E (pt) 2005-01-31
ZA987662B (en) 2000-02-25
EP0898969A3 (de) 2001-02-07
DE69826593T2 (de) 2005-02-10
EP1477184A2 (de) 2004-11-17
EP0898969A2 (de) 1999-03-03
CN1211449A (zh) 1999-03-24
ATE277631T1 (de) 2004-10-15
US6787146B2 (en) 2004-09-07
JP3049016B2 (ja) 2000-06-05
CA2245425C (en) 2006-12-12
EP0898969B1 (de) 2004-09-29
ES2227783T3 (es) 2005-04-01
BR9803232A (pt) 2000-01-11
US20020058046A1 (en) 2002-05-16
AR016396A1 (es) 2001-07-04
US20040223982A1 (en) 2004-11-11
DE69826593D1 (de) 2004-11-04
NZ331529A (en) 1999-03-29

Similar Documents

Publication Publication Date Title
NO20003302L (no) Vaksine
ID22500A (id) Turunan sulfonamida
ID24430A (id) Turunan-turunan benzamidina
DE69831181D1 (de) Positionsbestimmung
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
ID23173A (id) Turunan pirol trisiklik atau pirazol
NO20006191D0 (no) Vaksine
DK0898969T3 (da) Neospora-vaccine
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE59710388D1 (de) Mikropolarimeter
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59803185D1 (de) Baulaser
NO20005599L (no) Vaksine
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
DE59804377D1 (de) Kryoventil
ATA86797A (de) Verschleissschuh
DE59800820D1 (de) Stiellose kniegelenkendoprothese
ATA46498A (de) Kunststoffgleitbahn
BR9701194A (pt) Hidrociclo
ATE421585T1 (de) Motlinhomologe
BR7700551U (pt) Outdor pro-post
BR9700394A (pt) Triolim
BR9701095A (pt) Desartropol